Searchable abstracts of presentations at key conferences in endocrinology

ea0019p384 | Thyroid | SFEBES2009

Thyroid abnormalities in pegylated interferon treated hepatitis C patients

Thaware P , Black N , Callender M , McDougall N , Patterson K , Stewart I , Courtney H

Interferon therapy for chronic hepatitis C infection has been associated with thyroid abnormalities. We sought to characterise the incidence of this in a cohort of treated hepatitis C patients receiving weekly pegylated interferon therapy in a tertiary Hepatology unit. Patients were scheduled to receive 24 or 48 weeks treatment with monthly thyroid function tests (TFTs). Data was collected from electronic treatment records of 154 consecutive patients and analysed by a single i...

ea0019p279 | Pituitary | SFEBES2009

Macroprolactinaemia: what is the long-term prognosis? Results from an original series of 55 patients after 10 years clinical follow-up

Wallace I , Satti N , Courtney H , Leslie H , Bell P , Hunter S , McCance D , Sheridan B , Atkinson A

Macroprolactinaemia is defined as hyperprolactinaemia with a predominance of macroprolactin. It is present in approx 15–36% of cases of hyperprolactinaemia. Controversy exists as to the clinical relevance of macroprolactinaemia with a number of short-term studies demonstrating fewer classical symptoms of hyperprolactinaemia. The long-term prognosis is unknown.We have previously reported the findings after 5 years follow-up of a cohort of 55 patients...